NYSE:NTRNutrien Stock Price, Forecast & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NTR shares have increased by 10.9% and is now trading at $35.48.
View which stocks have been most impacted by Coronavirus.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 6 hold ratings, 15 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for Nutrien.

Nutrien will be holding an earnings conference call on Monday, August 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Nutrien Ltd (NYSE:NTR) issued its quarterly earnings data on Wednesday, May, 6th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.08. The company earned $4.19 billion during the quarter, compared to analysts' expectations of $3.44 billion. Nutrien had a return on equity of 4.66% and a net margin of 4.49%. Nutrien's revenue for the quarter was up 12.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.20 earnings per share.
View Nutrien's earnings history.

Nutrien declared a quarterly dividend on Wednesday, May 6th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.45 per share on Friday, July 17th. This represents a $1.80 annualized dividend and a dividend yield of 5.07%. The ex-dividend date is Monday, June 29th.
View Nutrien's dividend history.

22 Wall Street analysts have issued 1 year price objectives for Nutrien's stock. Their forecasts range from $36.00 to $70.00. On average, they expect Nutrien's share price to reach $49.30 in the next twelve months. This suggests a possible upside of 39.0% from the stock's current price.
View analysts' price targets for Nutrien.

News headlines about NTR stock have trended very positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Nutrien earned a coverage optimism score of 4.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about Nutrien.

Nutrien saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 2,330,000 shares, a decrease of 24.6% from the July 15th total of 3,090,000 shares. Based on an average daily trading volume, of 1,460,000 shares, the days-to-cover ratio is presently 1.6 days. Currently, 0.4% of the company's shares are sold short.
View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include Scotts Miracle-Gro (SMG), CF Industries (CF), Mosaic (MOS), ICL Group (ICL), Nufarm (NUF), American Vanguard (AVD), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), Eden Research (EDEN), China Green Agriculture (CGA) and Bion Environmental Technologies (BNET).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include General Electric (GE), Bank of America (BAC), Cimarex Energy (XEC), Johnson & Johnson (JNJ), Intel (INTC), AT&T (T), Exxon Mobil (XOM), Micron Technology (MU), Verizon Communications (VZ) and Pfizer (PFE).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a number of institutional and retail investors. Top institutional shareholders include CIBC Asset Management Inc (1.49%), Letko Brosseau & Associates Inc. (0.98%), Swiss National Bank (0.43%), Sumitomo Mitsui Trust Holdings Inc. (0.41%), Cambiar Investors LLC (0.33%) and ARGA Investment Management LP (0.33%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Addenda Capital Inc., Cambiar Investors LLC, Intact Investment Management Inc., Letko Brosseau & Associates Inc., Beech Hill Advisors Inc., UBS Group AG, and M&G Investment Management Ltd..

NTR stock was acquired by a variety of institutional investors in the last quarter, including ARGA Investment Management LP, QV Investors Inc., CIBC Asset Management Inc, Terril Brothers Inc., Swiss National Bank, PM CAPITAL Ltd, Sicart Associates LLC, and M&T Bank Corp.

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $35.48.

Nutrien has a market capitalization of $20.22 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]